Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China · Delayed Price · Currency is CNY 24.49
-0.81 (-3.20%)
Apr 28, 2026, 3:04 PM CST
SHE:002773 Revenue
Chengdu Kanghong Pharmaceutical Group had revenue of 1.05B CNY in the quarter ending March 31, 2026, a decrease of -12.70%. This brings the company's revenue in the last twelve months to 4.43B, down -2.76% year-over-year. In the year 2025, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.59B with 2.98% growth.
Revenue (ttm)
4.43B
Revenue Growth
-2.76%
P/S Ratio
5.09
Revenue / Employee
991.69K
Employees
4,462
Market Cap
22.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.59B | 132.48M | 2.98% |
| Dec 31, 2024 | 4.45B | 495.20M | 12.51% |
| Dec 31, 2023 | 3.96B | 568.43M | 16.77% |
| Jan 1, 2023 | 3.39B | -216.32M | -6.00% |
| Jan 1, 2022 | 3.61B | 309.92M | 9.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Livzon Pharmaceutical Group | 11.71B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.01B |
| Hubei Jumpcan Pharmaceutical | 5.90B |
| Kangmei Pharmaceutical | 5.25B |
| Betta Pharmaceuticals | 3.73B |
| Jilin Aodong Pharmaceutical Group | 2.34B |